Skip to content
healthcare.dev

DABIGATRAN ETEXILATE

NDC 59651-973, DABIGATRAN ETEXILATE, capsule, from Aurobindo Pharma Limited.

Product NDC
59651-973
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208039
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59651-973 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DABIGATRAN ETEXILATE MESYLATE75 mg/1

Pharmacologic classes

Direct Thrombin Inhibitor [EPC]; Thrombin Inhibitors [MoA]

Package NDCNDC-11Package
59651-973-605965109736060 CAPSULE in 1 BOTTLE (59651-973-60)
59651-973-615965109736110 BLISTER PACK in 1 CARTON (59651-973-61) / 6 CAPSULE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5b196b1f-408e-4615-b980-9f822adff835
  • NADAC price for package 59651097360

    GET /v1/drugs/nadac/59651097360

Use it

Look up 59651-973 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59651-973 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59651-973. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.